{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:36:56Z","timestamp":1790818616823,"version":"4.1.0"},"reference-count":114,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"publisher","award":["PI14\/00798"],"award-info":[{"award-number":["PI14\/00798"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In recent years, the relevance of the immune system to fight cancer has led to the development of immunotherapy, including the adoptive cell transfer of immune cells, such as natural killer (NK) cells and chimeric antigen receptors (CAR)-modified T cells. The discovery of donor NK cells\u2019 anti-tumor activity in acute myeloid leukemia patients receiving allogeneic stem cell transplantation (allo-SCT) was the trigger to conduct many clinical trials infusing NK cells. Surprisingly, many of these studies did not obtain optimal results, suggesting that many different NK cell parameters combined with the best clinical protocol need to be optimized. Various parameters including the high array of activating receptors that NK cells have, the source of NK cells selected to treat patients, different cytotoxic mechanisms that NK cells activate depending on the target cell and tumor cell survival mechanisms need to be considered before choosing the best immunotherapeutic strategy using NK cells. In this review, we will discuss these parameters to help improve current strategies using NK cells in cancer therapy. Moreover, the chimeric antigen receptor (CAR) modification, which has revolutionized the concept of immunotherapy, will be discussed in the context of NK cells. Lastly, the dark side of NK cells and their involvement in inflammation will also be discussed.<\/jats:p>","DOI":"10.3390\/ijms18091868","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T10:39:15Z","timestamp":1504003155000},"page":"1868","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Natural Killer Cells: Angels and Devils for Immunotherapy"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-2693","authenticated-orcid":false,"given":"Beatriz","family":"Mart\u00edn-Antonio","sequence":"first","affiliation":[{"name":"Department of Hematology, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"},{"name":"Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Su\u00f1e","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"},{"name":"Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Perez-Amill","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Castella","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"},{"name":"Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Urbano-Ispizua","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"},{"name":"Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1309\/Q49CRJ030L22MHLF","article-title":"The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders","volume":"127","author":"Morice","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: Natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1824-7288-35-44","article-title":"Transplantation and innate immunity: The lesson of natural killer cells","volume":"35","author":"Bertaina","year":"2009","journal-title":"Ital. J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"17","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/bmt.2008.398","article-title":"Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones","volume":"43","author":"Feuchtinger","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.b.21508","article-title":"Markers and function of human NK cells in normal and pathological conditions","volume":"92","author":"Marcenaro","year":"2017","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Horowitz, A., Strauss-Albee, D.M., Leipold, M., Kubo, J., Nemat-Gorgani, N., Dogan, O.C., Dekker, C.L., Mackey, S., Maecker, H., and Swan, G.E. (2013). Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med., 5.","DOI":"10.1126\/scitranslmed.3006702"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Milush","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen","volume":"189","author":"Foley","year":"2012","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83416","article-title":"Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells","volume":"7","author":"Takeda","year":"2001","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: The expanding network of non-apoptotic cell death pathways","volume":"15","author":"Linkermann","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cmi.2009.3","article-title":"Cell death mechanisms induced by cytotoxic lymphocytes","volume":"6","author":"Zenteno","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","article-title":"Crosstalk between apoptosis, necrosis and autophagy","volume":"1833","author":"Nikoletopoulou","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood-2009-12-261487","article-title":"Elucidation of the integrin LFA-1-mediated signaling pathway of actin polarization in natural killer cells","volume":"116","author":"Mace","year":"2010","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/cdd.2013.59","article-title":"Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis","volume":"20","author":"Susanto","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/hsz-2013-0238","article-title":"Are all granzymes cytotoxic in vivo?","volume":"395","author":"Joeckel","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.4049\/jimmunol.0802307","article-title":"Ignition of p53 bomb sensitizes tumor cells to granzyme K-mediated cytolysis","volume":"182","author":"Hua","year":"2009","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.18632\/oncotarget.3461","article-title":"Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2007.08.001","article-title":"H is for helper: Granzyme H helps granzyme B kill adenovirus-infected cells","volume":"28","author":"Waterhouse","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.1003409","article-title":"Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells","volume":"186","author":"Saini","year":"2011","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1182\/blood-2013-10-532531","article-title":"Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein","volume":"123","author":"Bachanova","year":"2014","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbmt.2016.04.009","article-title":"Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial","volume":"22","author":"Lee","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/1078-0432.CCR-15-1604","article-title":"Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients","volume":"22","author":"Curti","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dolstra, H., Roeven, M.W.H., Spanholtz, J., Hangalapura, B.N., Tordoir, M., Maas, F., Leenders, M., Bohme, F., Kok, N., and Trilsbeek, C. (2017). Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients. Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-16-2981"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2015.12.028","article-title":"Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation","volume":"22","author":"Shaffer","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/pbc.25555","article-title":"Natural killer cell therapy in children with relapsed leukemia","volume":"62","author":"Rubnitz","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kottaridis, P.D., North, J., Tsirogianni, M., Marden, C., Samuel, E.R., Jide-Banwo, S., Grace, S., and Lowdell, M.W. (2015). Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123416"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2141.2008.07340.x","article-title":"Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation","volume":"143","author":"Shi","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/2326-6066.CIR-15-0118","article-title":"Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors","volume":"4","author":"Yang","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1250051","DOI":"10.1080\/2162402X.2016.1250051","article-title":"Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma","volume":"5","author":"Leivas","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CJI.0000000000000059","article-title":"Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients","volume":"38","author":"Szmania","year":"2015","journal-title":"J. Immunother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14570","article-title":"Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jcyt.2015.07.011","article-title":"A phase I\/II trial of interleukin-15\u2013stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors","volume":"17","author":"Fernandez","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lin, M., Liang, S., Wang, X., Liang, Y., Zhang, M., Chen, J., Niu, L., and Xu, K. (2017). Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer. Oncotarget.","DOI":"10.18632\/oncotarget.17804"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2217\/imt.09.47","article-title":"Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: A phase I clinical study","volume":"1","author":"Barkholt","year":"2009","journal-title":"Immunotherapy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2007-09-110312","article-title":"Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components","volume":"111","author":"Alici","year":"2008","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3109\/14653249.2010.504770","article-title":"Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor","volume":"12","author":"Sutlu","year":"2010","journal-title":"Cytotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e1219007","DOI":"10.1080\/2162402X.2016.1219007","article-title":"Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma","volume":"5","author":"Granzin","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fimmu.2017.00774","article-title":"Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy","volume":"8","author":"Gao","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","article-title":"The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD","volume":"63","author":"Bishara","year":"2004","journal-title":"Tissue Antigens"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2003.04604.x","article-title":"T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation","volume":"123","author":"Lowe","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Shah, N., Martin-Antonio, B., Yang, H., Ku, S., Lee, D.A., Cooper, L.J.N., Decker, W.K., Li, S., Robinson, S.N., and Sekine, T. (2013). Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076781"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/hum.2009.142","article-title":"Fifteen years of gene therapy based on chimeric antigen receptors: \u201cAre we nearly there yet?\u201d","volume":"20","author":"Dotti","year":"2009","journal-title":"Human Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Liu, E., Tong, Y., Dotti, G., Shaim, H., Savoldo, B., Mukherjee, M., Orange, J., Wan, X., Lu, X., and Reynolds, A. (2017). Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent anti-tumor activity. Leukemia.","DOI":"10.1038\/leu.2017.226"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/14653249.2012.671519","article-title":"A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies","volume":"14","author":"Shimasaki","year":"2012","journal-title":"Cytotherapy"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1158\/2326-6066.CIR-14-0114","article-title":"Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice","volume":"3","author":"Chu","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Chen, K.H., Wada, M., Pinz, K.G., Liu, H., Lin, K.W., Jares, A., Firor, A.E., Shuai, X., Salman, H., and Golightly, M. (2017). Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor. Leukemia.","DOI":"10.1038\/leu.2017.8"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molonc.2013.12.001","article-title":"Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells","volume":"8","author":"Jiang","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/leu.2013.279","article-title":"CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma","volume":"28","author":"Chu","year":"2014","journal-title":"Leukemia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/mt.2014.219","article-title":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2\/HER2-specific chimeric antigen receptor","volume":"23","author":"Schonfeld","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zhang, C., Burger, M.C., Jennewein, L., Genssler, S., Schonfeld, K., Zeiner, P., Hattingen, E., Harter, P.N., Mittelbronn, M., and Tonn, T. (2016). ErbB2\/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. J. Natl. Cancer Inst., 108.","DOI":"10.1093\/jnci\/djv375"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00262-015-1669-5","article-title":"Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma","volume":"64","author":"Seidel","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1119354","DOI":"10.1080\/2162402X.2015.1119354","article-title":"Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival","volume":"5","author":"Genssler","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4939-3684-7_20","article-title":"In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells","volume":"1441","author":"Lowe","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ymthe.2017.06.012","article-title":"Engineering Natural Killer Cells for Cancer Immunotherapy","volume":"25","author":"Rezvani","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CJI.0000000000000082","article-title":"Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12\/SDF-1\u03b1-secreting Glioblastoma","volume":"38","author":"Muller","year":"2015","journal-title":"J. Immunother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.200324533","article-title":"IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors","volume":"33","author":"Sivori","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","article-title":"CD56brightCD16\u2212 killer Ig-like receptor\u2212 NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation","volume":"178","author":"Romagnani","year":"2007","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Denman, C.J., Senyukov, V.V., Somanchi, S.S., Phatarpekar, P.V., Kopp, L.M., Johnson, J.L., Singh, H., Hurton, L., Maiti, S.N., and Huls, M.H. (2012). Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030264"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/cdd.2014.120","article-title":"Transmissible cytotoxicity of Multiple Myeloma cells by NK cells mediated by vesicle trafficking","volume":"22","author":"Najjar","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1600-0854.2009.00973.x","article-title":"Endocytosis and intracellular trafficking of human natural killer cell receptors","volume":"10","author":"Masilamani","year":"2009","journal-title":"Traffic"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Huergo-Zapico, L., Acebes-Huerta, A., Gonzalez-Rodriguez, A.P., Contesti, J., Gonzalez-Garcia, E., Payer, A.R., Villa-Alvarez, M., Fernandez-Guizan, A., Lopez-Soto, A., and Gonzalez, S. (2014). Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108326"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e1001224","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1152\/physiol.00032.2013","article-title":"When cells become organelle donors","volume":"28","author":"Rogers","year":"2013","journal-title":"Physiology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"597","DOI":"10.18632\/aging.100341","article-title":"Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: Exchange of lysosomal pool","volume":"3","author":"Yasuda","year":"2011","journal-title":"Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/cmi.2014.30","article-title":"Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA\/B expression","volume":"11","author":"Xie","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/neuonc\/now061","article-title":"IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression","volume":"18","author":"Zhang","year":"2016","journal-title":"Neuro Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellimm.2006.03.002","article-title":"Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression","volume":"239","author":"Song","year":"2006","journal-title":"Cell. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Semeraro, M., Rusakiewicz, S., Minard-Colin, V., Delahaye, N.F., Enot, D., Vely, F., Marabelle, A., Papoular, B., Piperoglou, C., and Ponzoni, M. (2015). Clinical impact of the NKp30\/B7-H6 axis in high-risk neuroblastoma patients. Sci. Transl. Med., 7.","DOI":"10.1126\/scitranslmed.aaa2327"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2017.00387","article-title":"Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma","volume":"8","author":"Weil","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","article-title":"Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74","volume":"23","author":"Lue","year":"2011","journal-title":"Cell Signal."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.4049\/jimmunol.180.11.7338","article-title":"Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D","volume":"180","author":"Krockenberger","year":"2008","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","article-title":"T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1172\/JCI87366","article-title":"Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies","volume":"126","author":"Ruella","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e1250050","DOI":"10.1080\/2162402X.2016.1250050","article-title":"Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G","volume":"6","author":"Kailayangiri","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V128.22.2115.2115","article-title":"Natural killer cells transfer antimicrobial and antitumoral Histone H2AZ to kill multiple myeloma cells contributing to transmissible cytotoxicity","volume":"128","author":"Najjar","year":"2016","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: A therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ray, A., Das, D.S., Song, Y., Richardson, P., Munshi, N.C., Chauhan, D., and Anderson, K.C. (2015). Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells. Leukemia, 10.","DOI":"10.1038\/leu.2015.11"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/cr.2017.90","article-title":"Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function","volume":"27","author":"Lee","year":"2017","journal-title":"Cell Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Liu, Y., Cheng, Y., Xu, Y., Wang, Z., Du, X., Li, C., Peng, J., Gao, L., Liang, X., and Ma, C. (2017). Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers. Oncogene.","DOI":"10.1038\/onc.2017.209"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1261242","DOI":"10.1080\/2162402X.2016.1261242","article-title":"IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients","volume":"6","author":"Tallerico","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/jiq062","article-title":"Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia","volume":"203","author":"Schmidt","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.4049\/jimmunol.176.10.6162","article-title":"MyD88-dependent IFN-\u03b3 production by NK cells is key for control of Legionella pneumophila infection","volume":"176","author":"Sporri","year":"2006","journal-title":"J. Immunol."},{"key":"ref_96","first-page":"4137563","article-title":"Expression and Function of Granzymes A and B in Escherichia coli Peritonitis and Sepsis","volume":"2017","author":"Stroo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000443401","article-title":"Granzymes A and B Regulate the Local Inflammatory Response during Klebsiella pneumoniae Pneumonia","volume":"8","author":"Stroo","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1038\/cddis.2014.74","article-title":"NK cell intrinsic regulation of MIP-1\u03b1 by granzyme M","volume":"5","author":"Baschuk","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Wei, H.M., Lin, L.C., Wang, C.F., Lee, Y.J., Chen, Y.T., and Liao, Y.D. (2016). Antimicrobial Properties of an Immunomodulator\u201415 kDa Human Granulysin. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156321"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1189\/jlb.4A0713-363RR","article-title":"NK cells kill mycobacteria directly by releasing perforin and granulysin","volume":"96","author":"Lu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheumatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.4049\/jimmunol.1000430","article-title":"A role for granzyme M in TLR4-driven inflammation and endotoxicosis","volume":"185","author":"Anthony","year":"2010","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/febs.13699","article-title":"Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.1317347111","article-title":"Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes","volume":"111","author":"Wensink","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.39857","article-title":"Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis","volume":"69","author":"Santiago","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.4049\/jimmunol.174.9.5243","article-title":"Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator","volume":"174","author":"Deng","year":"2005","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","article-title":"TRAIL signalling: Decisions between life and death","volume":"39","author":"Falschlehner","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/sj.emboj.7600325","article-title":"CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells","volume":"23","author":"Barnhart","year":"2004","journal-title":"EMBO J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.celrep.2017.02.037","article-title":"CD95\/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response","volume":"18","author":"Qadir","year":"2017","journal-title":"Cell Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2017.01.021","article-title":"The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2","volume":"65","author":"Hartwig","year":"2017","journal-title":"Mol. Cell."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Del Fabbro, E., Skoro, N., and Brian, C. (2014). The prevalence of cachexia among patients with solid and hematologic malignancies at a National Cancer Institute (NCI)-designated cancer center in the 12 months prior to death. J. Clin. Oncol., 32.","DOI":"10.1200\/jco.2014.32.15_suppl.e20642"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/9\/1868\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:43:34Z","timestamp":1760208214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/9\/1868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":114,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["ijms18091868"],"URL":"https:\/\/doi.org\/10.3390\/ijms18091868","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}